Clinical trial
B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.
NCT07236177
Study timeline
Study start (actual)2026-02-03Date precision: day
Registry last updated2026-02-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Pancreatic Cancerunresolved
Pulmonary Cancerunresolved
Volatile Organic Compoundunresolved
Glycosidase Activityunresolved
Probesunresolved
Tumor Markers, Biologicalunresolved
Interventions
blood plasma sampleBIOLOGICAL
blood samplingBIOLOGICAL
Sponsors & collaborators
Poitiers University Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07236177 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.